UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Journal of thrombosis and haemostasis, 2019-07, Vol.17 (7), p.1085-1096

2019

Volltextzugriff (PDF)

Enhancing the pharmacokinetic properties of recombinant factor VIII: first‐in‐human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.670-678

2013

Volltextzugriff (PDF)

Haemophilia patients’ unmet needs and their expectations of the new extended half‐life factor concentrates

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.566-574

2017

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

British journal of haematology, 2020-11, Vol.191 (3), p.476-485

2020

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.494-502

2020

Volltextzugriff (PDF)

Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion

PloS one, 2015-12, Vol.10 (12), p.e0145012-e0145012

2015

Volltextzugriff (PDF)

Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.238-246

2017

Volltextzugriff (PDF)

HOw Patients view Extended half‐life products: Impressions from real‐world experience (The HOPE study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.814-820

2019

Volltextzugriff (PDF)

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

The American journal of clinical nutrition, 2005, Vol.81 (1), p.230S-242S

2005

Volltextzugriff (PDF)

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

PloS one, 2019-03, Vol.14 (3), p.e0212023

2019

Volltextzugriff (PDF)

A characterization of ABL‐101 as a potential tracer for clinical fluorine‐19 MRI

NMR in biomedicine, 2020-01, Vol.33 (1), p.e4212-n/a

2020

Volltextzugriff (PDF)

Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid

Biochimica et biophysica acta, 2013-06, Vol.1830 (6), p.3447-3453

2013

Volltextzugriff (PDF)

Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles

Carbohydrate polymers, 2024-11, Vol.343, p.122505, Article 122505

2024

Volltextzugriff (PDF)

Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning

Kidney international, 2014-07, Vol.86 (1), p.199-207

2014

Volltextzugriff (PDF)

Biocompatibility of boron nitride nanotubes: An up-date of in vivo toxicological investigation

International journal of pharmaceutics, 2013-02, Vol.444 (1-2), p.85-88

2013

Volltextzugriff (PDF)

Apparent Half-Lives of Dioxins, Furans, and Polychlorinated Biphenyls as a Function of Age, Body Fat, Smoking Status, and Breast-Feeding

Environmental health perspectives, 2009-03, Vol.117 (3), p.417-425

2009

Volltextzugriff (PDF)

Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive

PloS one, 2018-04, Vol.13 (4), p.e0195953-e0195953

2018

Volltextzugriff (PDF)

Two compartment pharmacokinetic model describes the intra‐articular delivery and retention of rhprg4 following ACL transection in the Yucatan mini pig

Journal of orthopaedic research, 2019-02, Vol.37 (2), p.386-396

2019

Volltextzugriff (PDF)

Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF

Scientific reports, 2020-04, Vol.10 (1), p.6301-1-6301-9, Article 6301

2020

Volltextzugriff (PDF)

Cerenkov Luminescence Imaging in Prostate Cancer: Not the Only Light That Shines

Journal of Nuclear Medicine, 2022-01, Vol.63 (1), p.29-35

2022

Volltextzugriff (PDF)

Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting

International journal of pharmaceutics, 2012-02, Vol.423 (2), p.461-470

2012

Volltextzugriff (PDF)

Albumin-binding domain extends half-life of glucagon-like peptide-1

European journal of pharmacology, 2021-01, Vol.890, p.173650, Article 173650

2021

Volltextzugriff (PDF)

First report on the safety and efficacy of an extended half‐life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-09, Vol.23 (5), p.689-696

2017

Volltextzugriff (PDF)

Functional cell types in taste buds have distinct longevities

PloS one, 2013-01, Vol.8 (1), p.e53399

2013

Volltextzugriff (PDF)

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.135-144

2023

Volltextzugriff (PDF)

1 – 25 von 21.196

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18.832)
Mit Volltextzugriff
(14.058)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(21.187)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(9.591)
Ingenta
(7.681)
EZB Electronic Journals Library
(6.448)
Wiley Online Library Journals
(5.174)
NUS Single-Journal Subscriptions
(4.637)
Wiley Online Library Full Collection 2018
(3.718)
Elsevier ScienceDirect Journals Complete
(2.958)
SpringerLink Journals - AutoHoldings
(2.844)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.706)
IngentaConnect Journals
(2.649)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.032)
Oxford Journals Online Current
(1.265)
Oxford Journals 2020 Medicine
(860)
Taylor & Francis Current Content Access
(768)
Taylor & Francis Online
(764)
Thieme Connect Journals
(709)
Taylor & Francis Journals Collection
(617)
JSTOR Complete Journals
(376)
Nexis Uni
(370)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?

Enhancing the pharmacokinetic properties of recombinant factor VIII: first‐in‐human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

Haemophilia patients’ unmet needs and their expectations of the new extended half‐life factor concentrates

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion

Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A

HOw Patients view Extended half‐life products: Impressions from real‐world experience (The HOPE study)

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

A characterization of ABL‐101 as a potential tracer for clinical fluorine‐19 MRI

Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid

Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles

Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning

Biocompatibility of boron nitride nanotubes: An up-date of in vivo toxicological investigation

Apparent Half-Lives of Dioxins, Furans, and Polychlorinated Biphenyls as a Function of Age, Body Fat, Smoking Status, and Breast-Feeding

Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive

Two compartment pharmacokinetic model describes the intra‐articular delivery and retention of rhprg4 following ACL transection in the Yucatan mini pig

Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF

Cerenkov Luminescence Imaging in Prostate Cancer: Not the Only Light That Shines

Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting

Albumin-binding domain extends half-life of glucagon-like peptide-1

First report on the safety and efficacy of an extended half‐life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A

Functional cell types in taste buds have distinct longevities

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

Aktive Filter

Suchergebnisse filtern